J1413
HCPCSInj delandistrogene mox rokl
Official HCPCS Level II long descriptor
Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
HCPCS Level II code J1413 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj delandistrogene mox rokl
Added to HCPCS: 2024-01-01
Nearby codes in J1
- J1327Eptifibatide injection
- J1335Ertapenem injection
- J1364Erythro lactobionate /500 mg
- J1370Inj, esomeprazole sod, 1 mg
- J1380Estradiol valerate 10 mg inj
- J1410Inj estrogen conjugate 25 mg
- J1411Inj, hemgenix, per tx dose
- J1412Inj roctavian ml 2x10^13vc g
- J1414Inj, beqvez, per tx dose
- J1426Injection, casimersen, 10 mg
- J1427Inj. viltolarsen
- J1428Inj, eteplirsen, 10 mg
- J1429Inj golodirsen 10 mg
- J1430Ethanolamine oleate 100 mg
- J1434Inj, focinvez, 1mg
- J1435Injection estrone per 1 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.